SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-22-016810
Filing Date
2022-04-29
Accepted
2022-04-29 16:08:16
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ubx-defa14a_20220624.htm DEFA14A 19349
2 GRAPHIC gozgycsuwjst000001.jpg GRAPHIC 503230
3 GRAPHIC gozgycsuwjst000002.jpg GRAPHIC 371609
  Complete submission text file 0001564590-22-016810.txt   1224976
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38470 | Film No.: 22875342
SIC: 2834 Pharmaceutical Preparations